SCHEMBL4750515

SCHEMBL4750515

Cc1cnc(C)c2oc(=O)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.43
▸ CYP1B1 Q16678 3/20 0.43
▸ KDM4E B2RXH2 5/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ MCL1 Q07820 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ GAA P10253 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ MAOB P27338 1/20 0.41
▸ MGAM O43451 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SI P14410 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ MGAM2 Q2M2H8 1/20 0.41
▸ CYP1A1 P04798 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HSD17B10 Q99714 3/20 0.39
▸ HPGD P15428 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8750126 0.74 KDM4E (0.47) CYP1A2CYP1B1KDM4EALDH1A1MCL1
SCHEMBL8737213 0.71 CCR1 (0.34) CCR1CCR5CCR8
SCHEMBL16806277 0.68 CCR1 (0.32) CYP1A2CYP1B1CCR1CCR5CCR8
SCHEMBL3362853 0.68 MAOB (0.59) CYP1A2KDM4EALDH1A1MCL1CYP3A4
SCHEMBL8750157 0.67 CTRC (0.48) CYP1A2CYP1B1KDM4EALDH1A1MCL1
SCHEMBL16806272 0.67 KDM4E (0.41) CYP1A2CYP1B1KDM4EALDH1A1MCL1
SCHEMBL19297000 0.66 GPR55 (0.50) CYP1A2CYP1B1KDM4EALDH1A1MCL1
SCHEMBL1115503 0.63 ALDH1A1 (0.66) CYP1A2CYP1B1KDM4EALDH1A1MCL1
SCHEMBL8750122 0.63 PON1 (0.49) KDM4EALDH1A1GAALMNAMAPT
SCHEMBL26346444 0.62 ERN1 (0.44) CYP1A2CYP1B1KDM4EALDH1A1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123756-A1 A PHARMACEUTICAL COMPOSITIONS CONTAINING LACTON TYPE PYRIDINE DERIVATIVES AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF ISCHEMIA SK CHEMICALS CO., LTD. (KR) 2008-10-16 — — WO claimed
WO-2008123756-A1 A PHARMACEUTICAL COMPOSITIONS CONTAINING LACTON TYPE PYRIDINE DERIVATIVES AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF ISCHEMIA SK CHEMICALS CO., LTD. (KR) 2008-10-16 — — WO disclosed
Send feedback